Receptors, Dopamine D2Receptors, Dopamine D3Receptors, Dopamine D1DopamineDopamine AgonistsDopamine AntagonistsReceptors, Dopamine D4QuinpiroleReceptors, DopamineBenzazepines2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineDopamine AgentsReceptors, Dopamine D5SulpirideErgolinesSalicylamidesApomorphineRacloprideCorpus StriatumDopamine Plasma Membrane Transport ProteinsSpiperoneHaloperidolFenoldopamDomperidoneDopamine Uptake InhibitorsTetrahydronaphthalenesNucleus AccumbensCocaineRats, Sprague-DawleyTetrahydroisoquinolinesAmphetamineBehavior, AnimalOxidopamineDopamine beta-HydroxylaseDose-Response Relationship, DrugSubstantia NigraNeostriatumMotor ActivityPhenanthridinesNeuronsPiperazinesPrefrontal CortexDopamine and cAMP-Regulated Phosphoprotein 32BerberineConditioning, OperantBrainLevodopaCatalepsyAntipsychotic AgentsBromocriptinePyrrolidinesDopaminergic NeuronsAnalysis of VarianceTyrosine 3-MonooxygenaseQuinolinesCaudate NucleusRats, WistarHomovanillic AcidMicrodialysisButaclamolPutamenVentral Tegmental AreaClozapineRadioligand AssayYawningNitrilesMethamphetamineRewardMesencephalonFlupenthixolalpha-MethyltyrosineDihydroxyphenylalanineBasal GangliaCocaine-Related DisordersTropanesReceptor, Adenosine A2ACentral Nervous System StimulantsHyperkinesisDyskinesia, Drug-InducedMSH Release-Inhibiting HormonePositron-Emission TomographyStereotyped BehaviorVesicular Monoamine Transport ProteinsPergolideLimbic SystemBenzamidesParkinson Disease, SecondaryBiogenic MonoaminesReserpineDrug InteractionsSynaptic TransmissionNomifensineLisurideSerotoninBrain ChemistryAntiparkinson AgentsAutoradiographyParkinsonian DisordersSchizophreniaOxazines